Drug intelligence / Profile preview

[11C]yohimbine + clonidine

Development stage
Unknown
Lead developer
Hospices Civils de Lyon
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous, Oral
01

Overview

[11C]yohimbine + clonidine is a research-grade combination used in positron emission tomography (PET) imaging studies, specifically those conducted by Hospices Civils de Lyon. The combination consists of [11C]yohimbine, a radiolabeled small molecule that acts as an antagonist for alpha-2 adrenergic receptors, and clonidine, a well-characterized alpha-2 adrenergic receptor agonist. In this experimental setup, [11C]yohimbine serves as the imaging tracer to visualize receptor distribution in the brain, while clonidine is administered to displace the tracer from the receptors. This pharmacological challenge allows researchers to quantify receptor occupancy and validate the kinetic modeling of the tracer, facilitating the study of the alpha-2 adrenergic system in humans.

Other names
[11C]Yohimbine + clonidine-Hospices Civils de Lyon
02

Targets

ADRA2A (α2A)

Beyond the preview

Go deeper on [11C]yohimbine + clonidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [11C]yohimbine + clonidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call